AIMOVIG vs SEMPREX-D

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 18, 2026·How we rate

Possible drug interaction. AIMOVIG and SEMPREX-D are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	AIMOVIG	SEMPREX-D
Rating	72/100	New
Pharmacy pays	—	—
Type	RX	RX
Active ingredient	ERENUMAB-AOOE	ACRIVASTINE AND PSEUDOEPHEDRINE HYDROCHLORIDE
Manufacturer	Amgen Inc	Endo Operations
Dosage forms	Injectable, Solution	Capsule
Drug class	—	—
Boxed warning	None	None
Half-life	—	roughly 3 to 16 hours — the label does not give one number, because the elimination half-life depends on urine pH: about 3 to 6 hours when urine pH is 5 (acidic), and about 9 to 16 hours when urine pH is 8 (alkaline)

aimovig semprex-d

Rating

72/100

New

Pharmacy pays

—

Type

Active ingredient

ERENUMAB-AOOE

ACRIVASTINE AND PSEUDOEPHEDRINE HYDROCHLORIDE

Manufacturer

Amgen Inc

Endo Operations

Dosage forms

Injectable, Solution

Capsule

Drug class

—

Boxed warning

None

Half-life

—

roughly 3 to 16 hours — the label does not give one number, because the elimination half-life depends on urine pH: about 3 to 6 hours when urine pH is 5 (acidic), and about 9 to 16 hours when urine pH is 8 (alkaline)

Frequently asked questions

What is the difference between Aimovig and Semprex-D?

Aimovig contains Erenumab-Aooe, while Semprex-D contains Acrivastine and Pseudoephedrine Hydrochloride — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.